REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,839,245 | -21.1% | 233,247 | -4.1% | 0.00% | 0.0% |
| Q2 2023 | $4,864,467 | -57.3% | 243,345 | -59.6% | 0.00% | -66.7% |
| Q1 2023 | $11,399,648 | -17.0% | 602,837 | -0.5% | 0.00% | -25.0% |
| Q4 2022 | $13,741,381 | +24.3% | 605,881 | +44.8% | 0.00% | 0.0% |
| Q3 2022 | $11,059,000 | -13.5% | 418,406 | -19.2% | 0.00% | 0.0% |
| Q2 2022 | $12,792,000 | +75.2% | 517,920 | +135.4% | 0.00% | +100.0% |
| Q1 2022 | $7,303,000 | +6.6% | 220,017 | +5.0% | 0.00% | 0.0% |
| Q4 2021 | $6,851,000 | -32.0% | 209,535 | -12.8% | 0.00% | -33.3% |
| Q3 2021 | $10,069,000 | -44.1% | 240,197 | -48.2% | 0.00% | -25.0% |
| Q2 2021 | $18,010,000 | +131.2% | 463,600 | +103.0% | 0.00% | +100.0% |
| Q1 2021 | $7,790,000 | -5.7% | 228,384 | +25.4% | 0.00% | 0.0% |
| Q4 2020 | $8,260,000 | +78.4% | 182,099 | +8.2% | 0.00% | 0.0% |
| Q3 2020 | $4,630,000 | -30.8% | 168,258 | -7.4% | 0.00% | 0.0% |
| Q2 2020 | $6,693,000 | -36.7% | 181,722 | -44.4% | 0.00% | -50.0% |
| Q1 2020 | $10,580,000 | -21.0% | 326,755 | -0.0% | 0.00% | 0.0% |
| Q4 2019 | $13,393,000 | +17.9% | 326,898 | +2.4% | 0.00% | +33.3% |
| Q3 2019 | $11,364,000 | -40.8% | 319,207 | -14.5% | 0.00% | -40.0% |
| Q2 2019 | $19,181,000 | -46.2% | 373,373 | -39.9% | 0.01% | -58.3% |
| Q1 2019 | $35,628,000 | +36.7% | 621,667 | +0.0% | 0.01% | +20.0% |
| Q4 2018 | $26,066,000 | -54.1% | 621,362 | -17.4% | 0.01% | -44.4% |
| Q3 2018 | $56,822,000 | +24.6% | 752,613 | +18.5% | 0.02% | +20.0% |
| Q2 2018 | $45,588,000 | +422.8% | 635,377 | +117.5% | 0.02% | +400.0% |
| Q1 2018 | $8,720,000 | -33.2% | 292,112 | -25.6% | 0.00% | -40.0% |
| Q4 2017 | $13,047,000 | +29.3% | 392,364 | +28.1% | 0.01% | +25.0% |
| Q3 2017 | $10,090,000 | +25.8% | 306,224 | -24.6% | 0.00% | +100.0% |
| Q2 2017 | $8,020,000 | +0.0% | 406,029 | -2.2% | 0.00% | -33.3% |
| Q1 2017 | $8,016,000 | +19.8% | 415,277 | +15.1% | 0.00% | +50.0% |
| Q4 2016 | $6,692,000 | +59.0% | 360,745 | +20.1% | 0.00% | +100.0% |
| Q3 2016 | $4,209,000 | +75.1% | 300,395 | -0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,404,000 | -25.8% | 300,452 | +0.1% | 0.00% | 0.0% |
| Q1 2016 | $3,242,000 | -34.9% | 300,200 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $4,983,000 | -24.6% | 300,200 | +0.1% | 0.00% | -33.3% |
| Q3 2015 | $6,609,000 | – | 300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |